|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 250.61 USD | +0.72% |
|
255.84 | +2.09% |
| Jul. 21 | Johnson & Johnson Insider Sold Shares Worth $5,792,686, According to a Recent SEC Filing | MT |
| Jul. 16 | Argus Lifts Johnson & Johnson Price Target to $290 From $275 | MT |
Published on 06/09/2026 at 05:30 pm EDT
Health-care companies rose as deal activity in the sector intensified.
GSK agreed to buy U.S. cancer-drug developer Nuvalent for $10.6 billion, the British pharmaceutical company's latest move to bolster its oncology business. That came on the heels of deals that saw Johnson & Johnson and Roche committing to spend billions of dollars on oncology acquisitions.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
06-09-26 1729ET
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
